Nipro Corporation, along with its various subsidiaries, operates as a diversified global enterprise primarily focusing on three key sectors: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device division is responsible for the development, production, and distribution of essential healthcare equipment. This includes products for injection-infusion therapies, dialysis treatments, and solutions for diabetes and cell culture applications, alongside artificial organ-related merchandise. Within the Pharmaceutical segment, Nipro offers a range of innovative combination products, such as dual chamber bags, pre-filled syringes, and convenient half-type kits. Furthermore, it provides comprehensive contract manufacturing services for orally administered, injectable, and topical drugs, complemented by robust logistic and distribution capabilities. The Pharma Packaging division specializes in delivering a complete portfolio of pharmaceutical containers. This encompasses a wide variety of glass products, including vials, ampoules, syringes, and cartridges, alongside glass tubes and glass bulbs designed for vacuum flasks, as well as critical components like rubber plugs. Beyond these core areas, Nipro also manufactures thermostable enzymes vital for clinical chemistry applications through its 'Other business' unit. Additionally, the corporation provides business management services. Established in Osaka, Japan, in 1947, Nipro Corporation maintains a significant international presence, serving markets across Japan, the Americas, Europe, and other parts of Asia.
—
Nipro Corporation, along with its various subsidiaries, operates as a diversified global enterprise primarily focusing on three key sectors: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device division is responsible for the development, production, and distribution of essential healthcare equipment. This includes products for injection-infusion therapies, dialysis treatments, and solutions for diabetes and cell culture applications, alongside artificial organ-related merchandise. Within the Pharmaceutical segment, Nipro offers a range of innovative combination products, such as dual chamber bags, pre-filled syringes, and convenient half-type kits. Furthermore, it provides comprehensive contract manufacturing services for orally administered, injectable, and topical drugs, complemented by robust logistic and distribution capabilities. The Pharma Packaging division specializes in delivering a complete portfolio of pharmaceutical containers. This encompasses a wide variety of glass products, including vials, ampoules, syringes, and cartridges, alongside glass tubes and glass bulbs designed for vacuum flasks, as well as critical components like rubber plugs. Beyond these core areas, Nipro also manufactures thermostable enzymes vital for clinical chemistry applications through its 'Other business' unit. Additionally, the corporation provides business management services. Established in Osaka, Japan, in 1947, Nipro Corporation maintains a significant international presence, serving markets across Japan, the Americas, Europe, and other parts of Asia.
—
Daily adjusted close
Nipro Corporation, along with its various subsidiaries, operates as a diversified global enterprise primarily focusing on three key sectors: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device division is responsible for the development, production, and distribution of essential healthcare equipment. This includes products for injection-infusion therapies, dialysis treatments, and solutions for diabetes and cell culture applications, alongside artificial organ-related merchandise. Within the Pharmaceutical segment, Nipro offers a range of innovative combination products, such as dual chamber bags, pre-filled syringes, and convenient half-type kits. Furthermore, it provides comprehensive contract manufacturing services for orally administered, injectable, and topical drugs, complemented by robust logistic and distribution capabilities. The Pharma Packaging division specializes in delivering a complete portfolio of pharmaceutical containers. This encompasses a wide variety of glass products, including vials, ampoules, syringes, and cartridges, alongside glass tubes and glass bulbs designed for vacuum flasks, as well as critical components like rubber plugs. Beyond these core areas, Nipro also manufactures thermostable enzymes vital for clinical chemistry applications through its 'Other business' unit. Additionally, the corporation provides business management services. Established in Osaka, Japan, in 1947, Nipro Corporation maintains a significant international presence, serving markets across Japan, the Americas, Europe, and other parts of Asia.